Anika Therapeutics Inc (ANIK)

EBITDA

$4.89M

Quarterly · Period ending: · USD

ANIK logo

ANIK EBITDA

Latest reported$4.89M
ANIK Quarterly EBITDA (-$400.00K → $4.89M)
High-resolution chart · PNG

ANIK ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-2,555,233
-2,069,121
2,369,735
-1,429,721
-192,675
-532,964
200,000
0
233,346
600,000
800,000
600,000
2,100,000
600,000
3,100,000
-200,000
500,000
300,000
-800,000
-500,000
-600,000
-1,000,000
-400,000
-800,000
-400,000
-100,000
-400,000
-400,000
-500,000
-200,000
-100,000
-500,000
-400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.